Article
ERBIN and phosphoglucomutase 3 deficiency.
Current opinion in immunology - 1 Oct 2023
Milner Joshua D
Abstract excerpt
ERBIN and phosphoglucomutase 3 (PGM3) mutations both lead to rare primary atopic disorders characterized by allergic disease and connective tissue abnormalities, though each disorder has its own rather unique pattern of multisystem presentations. Pathway studies show how ERBIN mutations allow for enhanced TGFb signaling, and prevent STAT3 from negative-regulating TGFb signaling. This likely explains many elements...
Topics
Join the communities discussing this publication.
